Viewing Study NCT00987766

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:01 PM
Ignite Modification Date: 2026-03-11 @ 9:09 PM
Study NCT ID: NCT00987766
Status: COMPLETED
Last Update Posted: 2017-07-02
First Post: 2009-09-30
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer
Sponsor: Vanderbilt-Ingram Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Extrahepatic Bile Duct Cancer View
None Gallbladder Cancer View
None Liver Cancer View
None Pancreatic Cancer View
None Periampullary Adenocarcinoma View
None Small Intestine Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None advanced adult primary liver cancer View
None stage III pancreatic cancer View
None stage IV pancreatic cancer View
None periampullary adenocarcinoma View
None small intestine adenocarcinoma View
None adenocarcinoma of the extrahepatic bile duct View
None adenocarcinoma of the gallbladder View
None unresectable extrahepatic bile duct cancer View
None unresectable gallbladder cancer View